Randomized trial shows enhanced glucose monitoring in diabetic models, indicating promising sensor stability and sensitivity.
The need for skin compatible continuous glucose monitoring (CGM) systems with high accuracy and stability has driven advancements in flexible microneedle-based sensors. Current solid microneedle-based CGMs face significant challenges, including enzyme instability and skin irritation. Hydrogel microneedles (HMNs), which become flexible after skin penetration, offer a promising alternative by reducing tissue irritation and improving skin integration. However, further optimization of hydrogel compositions is needed to enhance conductivity, stability, and long-term glucose monitoring performance. This study presents a new enzyme-free HMN-based CGM sensor, combining poly(3,4-ethylenedioxythiophene) sulfonate (PEDOT:PSS), gold nanoparticles (AuNPs), and polyvinylpyrrolidone (PVP). A new dual activation−regeneration strategy was employed to enhance the sensitivity and stability of glucose measurements for continuous monitoring. The proposed fully flexible CGM device, termed the HMN-P4Au sensor, was validated in vivo using a diabetic rat model, demonstrating a mean absolute relative difference (MARD) of 14.5% compared to standard glucometers. Notably, the sensor maintained stable readings with less than 14% signal degradation over 3 days. To examine the translational potential of the HMN-P4Au sensor, the gold-based sensing strategy was further evaluated in pig models, confirming its ability to reliably track both increases and decreases in glucose levels.
No takes yet. Share an insight, caveat, or question.
GhavamiNejad et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: